Table 3.
N | 2-Year cumulative incidence (%) | 95 % Confidence interval | |
---|---|---|---|
Entire cohort | 1121 | 16.37 | 14.22–18.80 |
No chemotherapy | 735 | 14.64 | 12.20–17.53 |
Non-taxane chemotherapy | 62 | 7.05 | 2.71–17.71 |
Taxane-based chemotherapy | 324 | 22.76 | 18.19–28.28 |